Skip to main content
. 2012 Feb 14;130(1):17–26. doi: 10.1590/S1516-31802012000100004

Table 4. Benefits resulting from treatment for diabetic inpatients and outpatients at the Center for Investigation of Perinatal Diabetes, HC-FMB-Unesp, 2007.

Benefits Diabetic inpatients (n = 7) Diabetic outpatients (n = 25)
Direct benefits*
Maternal:
DB1 - disease treatment 14,294.74 2,407.61
DB2 - difference in cost between successful and unsuccessful treatment 10,625.85 28,185.78
DB3 - number of hospitalizations/visits avoided during pregnancy 2,748.13 267.15
DB4 - number of hospital days avoided during gestation 631.14 -
DB5 - number of hospital days avoided during childbirth 2,435.59 6,855.09
DB6 - difference in cost between cesarean and vaginal delivery 40.43 169.58
Infant:
DB7 - number of infant hospital days avoided (rooming-in) 104.42 27.17
DB8 - number of infant hospital days avoided (nursery) 216.90 559.48
DB9 - ICU stay 12,988.29 548.20
Total direct benefits 44,085.57 37,901.12
Indirect benefits*
Maternal:
IB1 - Maternal mortality 30,115.24 43,615.18
Infant:
IB2 - Perinatal mortality§ 146,032.99 219,049.49
Total indirect benefits 176,148.24 262,664.68
Total benefits (US$)* 220,233.78 300,565.80

*Cost in United States dollars;Considering infant ICU hospitalization rate to be 11.0% (16.0% - 5.0%) for the inpatient group and 0.65% (3.95% - 3.3%) for the outpatient group; Considering maternal mortality rate to be 2%21; §Considering average perinatal mortality rate to be 4.5% (2.8 - 6.2%)23,24,25,26,27; ICU = intensive care unit.